Amil Sharma¹*, Sarvesha Bhondwe², Rupali Balpande³, Arpit Sikri⁴, Sharmishtha Sharma⁵ and Nirmal Tawar⁶

¹Senior Lecturer, Department of Conservative Dentistry and Endodontics, Maharana Pratap College of Dentistry and Research Centre, Gwalior, Madhya Pradesh, India

²Professor and Head, Department of Conservative Dentistry and Endodontics, Y C M M & R D F’s Dental College and Hospital, Ahmednagar, India

³Private practitioner Nagpur, Maharashtra, India

⁴Reader, Bhojia Dental College Baddi, Himachal Pradesh, India

⁵Private Practitioner, Gwalior, Madhya Pradesh, India

⁶Private Practitioner, Hoshangabad, Madhya Pradesh, India

*Corresponding Author: Amil Sharma, Senior Lecturer, Department of Conservative Dentistry and Endodontics, Maharana Pratap College of Dentistry and Research Centre, Gwalior, Madhya Pradesh, India.

Received: June 21, 2021; Published: July 14, 2021

Abstract

In 2019, an unknown virus known as Covid-19 was discovered in Wuhan, China. The first case of Covid-19 was discovered in India on January 30, 2020. In March 2020 it was declared as a global pandemic by World Health Organization. In 2021 India faced the 2^nd wave of Covid-19. Among the patients recovered from Covid19, few developed opportunistic infection with Black fungus also known as Mucormycosis. Diabetes Mellitus was found to be a risk factor in mucormycosis. The main aim of this article is to conduct a detailed review of mucormycosis infection.

Keywords: Mucormycosis; Covid 19; Steroids; Diabetes Mellitus

References

1. Awadhesh Kumar Singh., et al. “Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India Diabetes and Metabolic Syndrome: Clinical Research and Reviews 1-29 (2021).
2. Ajit Auluck. “Maxillary necrosis by mucormycosis. A case report and literature review”. Medicina Oral, Patologia Oral, Cirugia Bucal 12 (2007): E360-364.
3. Syeda Neelam Afroze., et al. “MadalaMucormycosis in a Diabetic Patient: A Case Report with an Insight into Its Pathophysiology”. Contemporary Clinical Dentistry (2017): 662-666.
4. Sandip Sarkar., et al. “COVID‑19 and orbital mucormycosis”. Indian Journal of Ophthalmology 4 (2021): 1002-1004.
5. Mehta S. “Rhino-Orbital Mucormycosis Associated With COVID-19”. Cureus9 (2020): e10726.
6. Ourania Nicolatou-Galitis., et al. “Mucormycosis presenting with dental pain and palatal ulcer in a patient with chronic myelomonocytic leukaemia: case report and literature review”. JMM Case Reports (2015): 1-8.
7. JG Song., et al. “Invasive pulmonary aspergillosis histologically mimicking mucormycosis”. The Ewha Medical Journal2 (2016): 65-68.
8. Aastha Maini., et al. “Sino-orbital mucormycosis in a COVID-19 patient: A case report”. International Journal of Surgery Case Reports 82 (2021): 105957.
9. Prakash H and Chakrabarti A. “Epidemiology of Mucormycosis in India”. Microorganisms 9 (2021): 523.
10. Amudhan A., et al. “Fungal Infection Emerging Into Oral Cavity: A Rare Case Report with Review of Literature Research Journal of Pharmaceutical, Biological and Chemical Sciences 5.6 (2014): 82-87.
11. Arvind Babu Rajendra Santosh., et al. “Fungal Infections of Oral Cavity: Diagnosis, Management, and Association with COVID-19 SN Comprehensive”. Clinical Medicine 3 (2021): 1373-1384.
12. Kumar JA., et al. “Mucormycosis in maxilla: Rehabilitation of facial defects using interim removable prostheses: A clinical case report”. Journal of Pharmacy and Bioallied Sciences 5 (2013): S163-165.
13. Sridhar Gontu Reddy., et al. “Oral mucormycosis: Need for early diagnosis!!” Journal of Dr. NTR University of Health Sciences2 (2014): 145-147.
14. Robert Branscomb. “An Overview of Mucormycosis ; laboratory medicine 6.33 (2002): 453-455.
15. Song G., et al. “Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China”. Mycopathologia 185 (2020): 599-606.
16. Kubin CJ., et al. “Characterization of Bacterial and Fungal Infections in Hospitalized Patients with COVID-19 and Factors Associated with Healthcare-associated Infections”. Open Forum Infectious Diseases (2021): ofab201.
17. Chander J., et al. “Mucormycosis: battle with the deadly enemy over a five-year period in India”. Journal of Fungi2 (2018): 46.
18. Prakash H and Chakrabarti A. “Global epidemiology of mucormycosis”. Journal of Fungi 5 (2019): 26.
19. Baker RD. “Mucormycosis-a new disease?” The Journal of the American Medical Association 163 (1957): 805-808.

Citation

Citation: Amil Sharma., et al. “Mucormycosis- A Post Covid Challenge in India" Acta Scientific Otolaryngology 3.8 (2021): 65-68.

Copyright

Copyright: © 2021 Amil Sharma., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.